SB697 FA1 TurnerTi-GRS(Untimely Filed)
5/8/2025 12:55:44 pm
FLOOR AMENDMENT
HOUSE OF REPRESENTATIVES
State of Oklahoma
SPEAKER:
CHAIR:
I move to amend SB697
Of the printed Bill
Page 1 Section 1 Lines 17
Of the Engrossed Bill
By removing Section 1 from the bill in its entirety and inserting in lieu
thereof, the following language:
(see attached)
AMEND TITLE TO CONFORM TO AMENDMENTS
Amendment submitted by: Tim Turner
Adopted: _____________________________
______________________________________
Reading Clerk

1 "SECTION 1. AMENDATORY 63 O.S. 2021, Section 2-309, as
2 last amended by Section 6, Chapter 308, O.S.L. 2024 (63 O.S. Supp.
3 2024, Section 2-309), is amended to read as follows:
4 Section 2-309. A. 1. Except for dosages medically required
5 for a period not to exceed forty-eight (48) hours which are
6 administered by or on direction of a practitioner, other than a
7 pharmacist, or medication dispensed directly by a practitioner,
8 other than a pharmacist, to an ultimate user, no controlled
9 dangerous substance included in Schedule II, which is a prescription
10 drug as determined under regulation promulgated by the Board of
11 Pharmacy, shall be dispensed without an electronic prescription of a
12 practitioner; provided, that in emergency situations, as prescribed
13 by the Board of Pharmacy by regulation, such drug may be dispensed
14 upon oral prescription reduced promptly to writing and filed by the
15 pharmacist in a manner to be prescribed by rules and regulations of
16 the Director of the Oklahoma State Bureau of Narcotics and Dangerous
17 Drugs Control.
18 2. Electronic prescribing shall be utilized for Schedules II,
19 III, IV and V, subject to the requirements set forth in 21 CFR,
20 Section 1311 et seq.
21 3. An electronic prescription with electronic signature may
22 serve as an original prescription, subject to the requirements set
23 forth in 21 CFR, Section 1311 et seq.
24
Req. No. 13682 Page 1

1 4. Prescriptions shall be retained in conformity with the
2 requirements of this section and Section 2-307 of this title. No
3 prescription for a Schedule II substance may be refilled.
4 5. The electronic prescription requirement provided for in this
5 section shall not apply to prescriptions for controlled dangerous
6 substances issued by any of the following:
7 a. a person licensed to practice veterinary medicine,
8 b. a practitioner who experiences temporary technological
9 or electrical failure or other extenuating
10 circumstance that prevents the prescription from being
11 transmitted electronically; provided, however, that
12 the practitioner documents the reason for this
13 exception in the medical record of the patient,
14 c. a practitioner, other than a pharmacist, who dispenses
15 directly to an ultimate user,
16 d. a practitioner who orders a controlled dangerous
17 substance to be administered through an on-site
18 pharmacy in:
19 (1) a hospital as defined in Section 1-701 of this
20 title,
21 (2) a nursing facility as defined in Section 1-1902
22 of this title,
23 (3) a hospice inpatient facility as defined in
24 Section 1-860.2 of this title,
Req. No. 13682 Page 2

1 (4) an outpatient dialysis facility,
2 (5) a continuum of care facility as defined in
3 Section 1-890.2 of this title, or
4 (6) a penal institution listed in Section 509 of
5 Title 57 of the Oklahoma Statutes,
6 e. a practitioner who orders a controlled dangerous
7 substance to be administered through a hospice program
8 including but not limited to a hospice program that
9 provides hospice services in the private residence of
10 a patient or in a long-term care facility where the
11 patient resides. As used in this subparagraph,
12 “hospice program” has the same meaning as provided by
13 Section 1-860.2 of this title,
14 f. a practitioner who writes a prescription to be
15 dispensed by a pharmacy located on federal property,
16 provided the practitioner documents the reason for
17 this exception in the medical record of the patient,
18 g. a practitioner that has received a waiver or extension
19 from his or her licensing board,
20 h. a practitioner who prescribes a controlled dangerous
21 substance for a supply that when taken as prescribed
22 would be consumed within seventy-two (72) hours, or
23
24
Req. No. 13682 Page 3

1 i. a practitioner who determines that an electronic
2 prescription cannot be issued in a timely manner and
3 the condition of the patient is at risk.
4 6. Electronic prescriptions may be utilized under the following
5 circumstances:
6 a. compounded prescriptions,
7 b. compounded infusion prescriptions, or
8 c. prescriptions issued under approved research
9 protocols.
10 7. A pharmacist who receives a written, oral or facsimile
11 prescription shall not be required to verify that the prescription
12 falls under one of the exceptions provided for in paragraph 6 of
13 this subsection. Pharmacists may continue to dispense medications
14 from otherwise valid written, oral or facsimile prescriptions that
15 are consistent with the provisions of this section.
16 8. Practitioners shall indicate in the health record of a
17 patient that an exception to the electronic prescription requirement
18 was utilized.
19 9. All prescriptions issued pursuant to paragraph 5 and
20 subparagraph c of paragraph 6 of this subsection shall be on an
21 official prescription form approved by the Oklahoma State Bureau of
22 Narcotics and Dangerous Drugs Control if not issued electronically.
23 All prescriptions issued pursuant to subparagraphs a and b of
24
Req. No. 13682 Page 4

1 para graph 6 of this subsection may be transmitted via written, oral,
2 or facsimile.
3 10. a. Practitioners shall be registered with the Oklahoma
4 State Bureau of Narcotics and Dangerous Drugs Control
5 in order to purchase official prescription forms.
6 Such registration shall include, but not be limited
7 to, the primary address and the address of each place
8 of business to be imprinted on official prescription
9 forms. Any change to a registered practitioner’s
10 registered address shall be promptly reported to the
11 practitioner’s licensing board and the Bureau by the
12 practitioner in a manner approved by the Bureau.
13 b. Where the Bureau has revoked the registration of a
14 registered practitioner, the Bureau may revoke or
15 cancel any official prescription forms in the
16 possession of the registered practitioner. Any
17 revocation or any suspension shall require the
18 registered practitioner to return all unused official
19 prescription forms to the Bureau within fifteen (15)
20 calendar days after the date of the written
21 notification.
22 c. A practitioner that has had any license to practice
23 terminated, revoked or suspended by a state or federal
24
Req. No. 13682 Page 5

1 agency may, upon restoration of such license or
2 certificate, register with the Bureau.
3 11. a. Official prescription forms shall be purchased at the
4 expense of the practitioner or the employer of the
5 practitioner from a list of vendors approved by the
6 Bureau.
7 b. Official prescription forms issued to a registered
8 practitioner shall be imprinted with the primary
9 address and may include other addresses listed on the
10 registration of the practitioner to identify the place
11 of origin. Such prescriptions shall be sent only to
12 the primary address of the registered practitioner.
13 c. Official prescription forms of a registered
14 practitioner shall be used only by the practitioner
15 designated on the official prescription form.
16 d. The Bureau may revoke or cancel official prescription
17 forms in possession of registered practitioners when
18 the license of such practitioner is suspended,
19 terminated or revoked.
20 e. Official prescription forms of registered
21 practitioners who are deceased or who no longer
22 prescribe shall be returned to the Bureau at a
23 designated address. If the registered practitioner is
24 deceased, it is the responsibility of the registered
Req. No. 13682 Page 6

1 practitioner’s estate or lawful designee to return
2 such forms.
3 f. The Bureau may issue official prescription forms to
4 employees or agents of the Bureau and other government
5 agencies for the purpose of preventing, identifying,
6 investigating and prosecuting unacceptable or illegal
7 practices by providers and other persons and assisting
8 in the recovery of overpayments under any program
9 operated by the state or paid for with state funds.
10 Such prescription forms shall be issued for this
11 purpose only to individuals who are authorized to
12 conduct investigations on behalf of the Bureau or
13 other government agencies as part of their official
14 duties. Individuals and agencies receiving such
15 prescription forms for this purpose shall provide
16 appropriate assurances to the Bureau that adequate
17 safeguards and security measures are in place to
18 prevent the use of such prescription forms for
19 anything other than official government purposes.
20 12. a. Adequate safeguards and security measures shall be
21 undertaken by registered practitioners holding
22 official prescription forms to assure against the
23 loss, destruction, theft or unauthorized use of the
24 forms. Registered practitioners shall maintain a
Req. No. 13682 Page 7

1 sufficient but not excessive supply of such forms in
2 reserve.
3 b. Registered practitioners shall immediately notify the
4 Bureau, in a manner designated by the Bureau, upon
5 their knowledge of the loss, destruction, theft or
6 unauthorized use of any official prescription forms
7 issued to them, as well as the failure to receive
8 official prescription forms within a reasonable time
9 after ordering them from the Bureau.
10 c. Registered practitioners shall immediately notify the
11 Bureau upon their knowledge of any diversion or
12 suspected diversion of drugs pursuant to the loss,
13 theft or unauthorized use of prescriptions.
14 B. 1. Except for dosages medically required for a period not
15 to exceed seventy-two (72) hours which are administered by or on
16 direction of a practitioner other than a pharmacist or medication
17 dispensed directly by a practitioner, other than a pharmacist, to an
18 ultimate user, or the circumstances provided for in paragraphs 5 and
19 6 of subsection A of this section, no controlled dangerous substance
20 included in Schedule III or IV, which is a prescription drug as
21 determined under regulation promulgated by the Board of Pharmacy,
22 shall be dispensed without an electronic prescription.
23 2. Any prescription for a controlled dangerous substance in
24 Schedule III, IV or V may not be filled or refilled more than six
Req. No. 13682 Page 8

1 (6) months after the date thereof or be refilled more than five
2 times after the date of the prescription, unless renewed by the
3 practitioner.
4 C. Whenever it appears to the Director of the Oklahoma State
5 Bureau of Narcotics and Dangerous Drugs Control that a drug not
6 considered to be a prescription drug under existing state law or
7 regulation of the Board of Pharmacy should be so considered because
8 of its abuse potential, the Director shall so advise the Board of
9 Pharmacy and furnish to the Board all available data relevant
10 thereto.
11 D. 1. “Prescription”, as used in this section, means a
12 written, oral or electronic order by a practitioner to a pharmacist
13 for a controlled dangerous substance for a particular patient, which
14 specifies the date of its issue, and the full name and address of
15 the patient and, if the controlled dangerous substance is prescribed
16 for an animal, the species of the animal, the name and quantity of
17 the controlled dangerous substance prescribed, the directions for
18 use, the name and address of the owner of the animal and, if
19 written, the signature of the practitioner. When electronically
20 prescribed, the full name of the patient may include the name and
21 species of the animal.
22 2. “Registered practitioner”, as used in this section, means a
23 licensed practitioner duly registered with the Oklahoma State Bureau
24
Req. No. 13682 Page 9

1 of N arcotics and Dangerous Drugs Control authorized to purchase
2 official prescription forms.
3 E. No person shall solicit, dispense, receive or deliver any
4 controlled dangerous substance through the mail, unless the ultimate
5 user is personally known to the practitioner and circumstances
6 clearly indicate such method of delivery is in the best interest of
7 the health and welfare of the ultimate user."
8
9 60-1-13682 GRS 05/08/25
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Req. No. 13682 Page 10

[DELETED: 5 AS C           O S L           ]
[DELETED:  P]
[DELETED:  P a a a a a a a]
[DELETED:  P a a a a a a a]
[DELETED:  P a c c p]
[DELETED:  P a P W A]
[DELETED:  P a O O O T O]
[DELETED:  P T a A]
[DELETED:  P R R]
[DELETED:  P]
[DELETED:  P G 0]